A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
Read more …Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly...

In an era where digital devices are everywhere, the term “screen time” has become a buzz phrase in discussions about technology’s impact on people’s lives. Parents are concerned about their children’s screen habits[1]. But what if this entire approach to screen time is fundamentally flawed?

While researchers have made advances in measuring screen use, a detailed critique of the research in 2020 revealed major issues[2]...

Read more

More Articles …